Filing Flows › Yarrow Bioscience (YARW) › Q2 2026 › vs Q1 2026
Yarrow Bioscience (YARW) Q2 2026 vs Q1 2026 (quarter over quarter)
Yarrow Bioscience's revenue rose $11K (+13%) from $86K in Q1 2026 to $97K in Q2 2026.
Yarrow Bioscience, Q2 2026: revenue $97K (+41% year over year), net loss $3.0M, operating cash flow −$2.0M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $97K | $86K | $11K | +13% |
| Other income, net | $95K | $231K | −$136K | -59% |
| Net loss | $3.0M | $3.6M | −$578K | -16% |
| Costs & expenses | $3.2M | $3.9M | −$703K | -18% |
| Operating costs | $3.2M | $3.9M | −$703K | -18% |
| Research & development | $788K | $817K | −$29K | -4% |
| General & admin | $2.4M | $3.1M | −$674K | -22% |
| Operating cash sources | $3.0M | $3.6M | −$578K | -16% |
| Depreciation & amortization | $6K | $6K | $0 | 0% |
| Share-based compensation | $436K | $474K | −$38K | -8% |
| Working capital & other | $573K | −$976K | $1.5M | — |
| Cash used in operations | $2.0M | $4.1M | −$2.1M | -51% |
| Net loss absorbed | $3.0M | $3.6M | −$578K | -16% |
Questions
How much did Yarrow Bioscience's revenue grow quarter over quarter in Q2 2026?
Yarrow Bioscience's revenue rose $11K (+13%) from $86K in Q1 2026 to $97K in Q2 2026.